To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Impaired fasting glycaemia
Impaired fasting glycaemia (IFG) is a pre-diabetic state of dysglycemia, associated with insulin resistance and increased risk cardiovascular pathology, although of lesser risk than Impaired glucose tolerance (IGT). IFG often progresses to type 2 diabetes mellitus, a recent study citing the average time for progression as less than three years. IFG is also a risk factor for mortality.
Additional recommended knowledge
It is characterised by an intermediately raised fasting glucose level, but less than would qualify for type 2 diabetes mellitus. On challenging with an oral glucose tolerance test, normal blood glucose levels are maintained after 2 hours, unlike IGT.
The criteria will continue to change as many endocrinologists believe an impaired fasting glycose may eventually include fasting glucose between a high 95-100 mg/dl.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Impaired_fasting_glycaemia". A list of authors is available in Wikipedia.|